Literature DB >> 25206981

Transjugular liver biopsy: results of 97 patients.

Halil Dönmez1, Güven Kahriman1, Nevzat Ozcan1, Ertuğrul Mavili1, Kemal Deniz2.   

Abstract

OBJECTIVE: To evaluate the feasibility and efficacy of transjugular liver biopsy in patients with contraindicated percutaneous biopsy.
MATERIALS AND METHODS: Between June 2005 and April 2010, 97 patients who were admitted for transjugular liver biopsy were enrolled in this retrospective study. All liver biopsies were obtained using an 18 gauge Quick-Core liver biopsy set through the right hepatic vein via the internal jugular vein. Clinical indication, histopathological diagnosis, and complications were noted.
RESULTS: Primary technical success was achieved in 93 (95.8%) patients. Hepatic veins could not be catheterized and opacified in two patients and in the remaining two patients the veins could be opacified and catheterized but we were not able to pass the biopsy needle into the hepatic vein because of the acute angle between the inferior vena cava and hepatic veins. At least two specimens were obtained from each patient. The most frequent histopathological diagnosis was cirrhosis. A subcutaneous hematoma around the puncture side was encountered in one patient.
CONCLUSION: Transjugular liver biopsy is a feasible and effective alternative in patients with contraindication for percutaneous biopsy.

Entities:  

Keywords:  Transjugular liver biopsy; liver biopsy; liver cirrhosis

Year:  2012        PMID: 25206981      PMCID: PMC4115860          DOI: 10.5152/balkanmedj.2011.022

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  24 in total

1.  Liver biopsy. II. The risk of needle biopsy.

Authors:  N ZAMCHECK; O KLAUSENSTOCK
Journal:  N Engl J Med       Date:  1953-12-24       Impact factor: 91.245

Review 2.  Liver biopsy sampling in chronic viral hepatitis.

Authors:  Maria Guido; Massimo Rugge
Journal:  Semin Liver Dis       Date:  2004-02       Impact factor: 6.115

3.  Transjugular liver biopsy: a retrospective analysis of 601 cases.

Authors:  Thomas Mammen; Shyamkumar N Keshava; C E Eapen; Lakshminarayan Raghuram; Vinu Moses; Kota Gopi; Narayanam Surendra Babu; Jeyamani Ramachandran; George Kurien
Journal:  J Vasc Interv Radiol       Date:  2008-03       Impact factor: 3.464

4.  Transjugular liver biopsy with an automated device.

Authors:  M Kardache; P Soyer; M Boudiaf; B Cochand-Priollet; J P Pelage; R Rymer
Journal:  Radiology       Date:  1997-08       Impact factor: 11.105

5.  Transjugular liver biopsy: a prospective study in 43 patients with the Quick-Core biopsy needle.

Authors:  A F Little; A B Zajko; P D Orons
Journal:  J Vasc Interv Radiol       Date:  1996 Jan-Feb       Impact factor: 3.464

6.  Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure.

Authors:  D Lebrec; G Goldfarb; C Degott; B Rueff; J P Benhamou
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

7.  Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients.

Authors:  H M Shulman; T Gooley; M D Dudley; T Kofler; R Feldman; D Dwyer; G B McDonald
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

8.  Percutaneous management of concomitant post-traumatic high vertebrovertebral and caroticojugular fistulas using balloons, coils, and a covered stent.

Authors:  Ian C Duncan; Pieter A Fourie
Journal:  J Endovasc Ther       Date:  2003-10       Impact factor: 3.487

9.  The quality of the fragment obtained by liver biopsy for staging chronic hepatitis.

Authors:  Ioan Sporea; Roxana Sirli; Alina Popescu; Marioara Cornianu; Corina Manciu; Mircea Focşa
Journal:  J Gastrointestin Liver Dis       Date:  2007-09       Impact factor: 2.008

10.  Transjugular liver biopsy in high-risk patients with hepatic disease.

Authors:  P M Velt; O G Choy; P M Shimkin; R J Link
Journal:  Radiology       Date:  1984-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.